SCHEMBL6695749

SCHEMBL6695749

CC(C)CCCSCCCC(C)(C)OP(N)(=O)O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BHMT Q93088 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6354715 0.89 GRM4 (0.35)
SCHEMBL6344061 0.88 GRM4 (0.34)
SCHEMBL6514133 0.87 SMPD1 (0.32)
SCHEMBL7631051 0.84 GRM4 (0.32)
SCHEMBL6346290 0.84 SMPD1 (0.35) BHMT
SCHEMBL6346655 0.81 SMPD1 (0.32)
SCHEMBL6352923 0.80 SMPD1 (0.33)
SCHEMBL6356286 0.77 GRM4 (0.32)
SCHEMBL12092688 0.76 ACACB (0.38)
SCHEMBL12953253 0.76 SMPD1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004532799-A 2004-10-28 JP claimed
EP-1363879-A2 SULFIDE AND DISULFIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES Esperion Therapeutics Inc. (US) 2003-11-26 EP claimed
WO-2002030884-A2 SULFIDE AND DISULFIDE COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES ESPERION THERAPEUTICS, INC. (US) 2002-04-18 WO claimed